TickerFactsScreenerDevelopers

CytomX Therapeutics, Inc. (CTMX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $14.75M2013: $8.70M2014: $64.40M2015: $59.82M2016: $104.64M2017: $177.55M2018: $247.58M2019: $188.43M2020: $191.86M2021: $205.53M2022: $193.65M2023: $17.17M2024: $38.05M2025: $12.67M$12.67M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$12.67M-66.7%
2024$38.05M+121.6%
2023$17.17M-91.1%
2022$193.65M-5.8%
2021$205.53M+7.1%
2020$191.86M+1.8%
2019$188.43M-23.9%
2018$247.58M+39.4%
2017$177.55M+69.7%
2016$104.64M+74.9%
2015$59.82M-7.1%
2014$64.40M+639.9%
2013$8.70M-41.0%
2012$14.75M—